Thrombosis Journal

Papers
(The median citation count of Thrombosis Journal is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
The disulfide bond Cys2724-Cys2774 in the C-terminal cystine knot domain of von Willebrand factor is critical for its dimerization and secretion53
Two cases of venous thromboembolism in siblings after splenectomy due to a novel PROC gene mutation41
Utilization of the Caprini risk assessment model(RAM) to predict venous thromboembolism after primary hip and knee arthroplasty: an analysis of the Healthcare Cost and Utilization Project(HCUP)38
Coexistence of antithrombin deficiency and suspected inferior vena cava atresia in an adolescent and his mother – case report and clinical implications37
Hyper-responsiveness to warfarin in a young patient with the VKORC1 -1639GA/CYP2C9*1*46 genotype: a case report30
Balancing the risks: continuous vs. interrupted anticoagulation during TAVI – what does the evidence say?29
Investigating the dual causative pathways linking immune cells and venous thromboembolism via Mendelian randomization analysis26
Catheter-directed therapy for pulmonary embolism in pediatrics: a systematic review and meta-analysis24
Association between inflammatory indices and preoperative deep vein thrombosis in patients undergoing total joint arthroplasty: a retrospective study23
Relationship between serum uric acid levels and pulmonary embolism: an age-based stratified analysis21
The efficacy of tranexamic acid treatment with different time and doses for traumatic brain injury: a systematic review and meta-analysis20
Comparison of deep vein thrombosis risks in acute respiratory distress syndrome caused by COVID-19 and bacterial pneumonia: a retrospective cohort study18
Association of elevated circulating monocyte-platelet aggregates with hypercoagulability in patients with nephrotic syndrome18
Hyperlipidemia in immune thrombocytopenia: a retrospective study17
Risk of recurrent venous thromboembolism and major bleeding according to risk factor profiles in Asian patients: a subgroup analysis EINSTEIN-Extension and EINSTEIN-CHOICE17
Application of the Khorana score for cancer-associated thrombosis prediction in patients of East Asian ethnicity undergoing ambulatory chemotherapy17
Clinical significance of D-dimer levels during acute period in ischemic stroke16
Use of the RCOG risk assessment model and biomarkers to evaluate the risk of postpartum venous thromboembolism16
Hemostatic potential of recombinant von Willebrand factor and standard or pegylated extended half-life recombinant factor VIII on thrombus formation under high shear flow15
Coagulation dysfunction events associated with echinocandins: a real-world study from FDA adverse event reporting system (FAERS) database15
Prevalence, risk, and outcome of deep vein thrombosis in acute respiratory distress syndrome15
A study of recurrent life-threatening thrombosis accompanied with the duplication of the factor IX gene14
Damage-associated molecular patterns and fibrinolysis perturbation are associated with lethal outcomes in traumatic injury14
Safety and efficacy of direct oral anticoagulants in stroke prevention in patients with atrial fibrillation complicated with anemia and/or thrombocytopenia: a retrospective cohort study14
Association between liver fibrosis and thrombotic or bleeding events in acute coronary syndrome patients13
Recurrent, life-threatening PE in the setting of popliteal vein aneurysm in pregnancy: a case report13
An in situ inferior vena cava ligation-stenosis model to study thrombin generation rates with flow13
Role of ticagrelor in the peri-thrombolytic phase for patients with ST-segment elevation myocardial infarction: a comprehensive review12
A case of acquired thrombotic thrombocytopenic purpura induced by acute severe hepatitis E: successfully treated by plasma exchange and rituximab12
Predictive ability of viscoelastic testing using ClotPro® for short-term outcome in patients with severe Covid-19 ARDS with or without ECMO therapy: a retrospective study11
The trends in the incidence and thrombosis-related comorbidities of antiphospholipid syndrome: a 14-year nationwide population-based study11
An optimal window of platelet reactivity by LTA assay for patients undergoing percutaneous coronary intervention11
Prevalence of venous thromboembolism and evaluation of a modified caprini risk assessment model: a single-centre, prospective cohort study involving patients undergoing lung resections for bronchiecta11
Comparison of VTE risk scores in guidelines for VTE diagnosis in nonsurgical hospitalized patients with suspected VTE11
Serum interleukin 1β and sP-selectin as biomarkers of inflammation and thrombosis, could they be predictors of disease severity in COVID 19 Egyptian patients? (a cross-sectional study)11
Association between antithrombotic therapy and mortality in patients hospitalized for COVID‑1911
Thrombin generation capacity is enhanced by low antithrombin activity and depends on the activity of the related coagulation factors11
Standard- versus intermediate-dose enoxaparin for anti-factor Xa guided thromboprophylaxis in critically ill patients with COVID-1911
Assessing outcomes after thrombectomy with or without iliac vein stenting for young provoked DVT patients with iliac vein stenosis11
The use of direct oral anticoagulants for thromboprophylaxis or treatment of cancer-associated venous thromboembolism: a meta-analysis and review of the guidelines10
Association between red cell distribution width-to-lymphocyte ratio and 30-day mortality in patients with ischemic stroke: a retrospective cohort study10
Circular RNA ciRs-126 promotes hypoxia/reoxygenation cardiac injury possibly through miR-2110
Temporal change in Syndecan-1 as a therapeutic target and a biomarker for the severity classification of COVID-1910
Colonization of Fusobacterium nucleatum is an independent predictor of poor prognosis in gastric cancer patients with venous thromboembolism: a retrospective cohort study10
A novel role for protein disulfide isomerase ERp18 in venous thrombosis10
Monitoring heparin therapy: stability of two different anti-Xa assays using blood samples collected in citrate-containing and CTAD tubes10
The effectiveness of atorvastatin for the prevention of deep vein thrombosis in cancer patients undergoing chemotherapy10
Current status of treatment of cancer-associated venous thromboembolism10
Tranexamic acid for the prevention and treatment of bleeding in surgery, trauma and bleeding disorders: a narrative review9
Point-of-care detection and differentiation of anticoagulant therapy - development of thromboelastometry-guided decision-making support algorithms9
Incidence, risk factors, and clinical impact of major bleeding in hospitalized patients with COVID-19: a sub-analysis of the CLOT-COVID Study9
Evaluation of the efficacy and safety of rivaroxaban compared to warfarin in patients with left ventricular apical thrombus: a randomized clinical trial9
Heparin-induced thrombocytopenia in extracorporeal membrane oxygenation-supported patients: a systematic review and meta-analysis9
Circulating LPS from gut microbiota leverages stenosis-induced deep vein thrombosis in mice9
Effects of combination therapy of antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a systematic review and meta-analysis9
The association between ROS1 rearrangement and risk of thromboembolic events in patients with advanced non-small cell lung cancer: a multicenter study in China9
Cancer incidence and mortality after a first-ever venous thrombosis: a cohort study in northern Sweden8
Superior sagittal sinus thrombosis in the course of mixed phenotype acute leukaemia treated with acute lymphoblastic leukaemia-like therapy—a case report8
A snake venom-analog peptide that inhibits SARS-CoV-2 and papain-like protease displays antithrombotic activity in mice arterial thrombosis model, without interfering with bleeding time8
Calibrated automated thrombogram II: removing barriers for thrombin generation measurements8
The well-defined antiphospholipid syndrome induced by COVID-19: a rare case report and review of the literature8
Early coagulopathy after pediatric out-of-hospital cardiac arrest: secondary analysis of a randomized clinical trial8
Prognostic value of characteristics of plaque combined with residual syntax score among patients with STEMI undergoing primary PCI: an intravascular optical coherence tomography study8
Asymptomatic and symptomatic deep venous thrombosis in hospitalized acutely ill medical patients: risk factors and therapeutic implications8
Thromboembolic and hemorrhagic risks after vaccination against SARS-CoV-2: a systematic review and meta-analysis of randomized controlled trials8
Patients with venous thromboembolism after spontaneous intracerebral hemorrhage: a review7
The use of infrared thermography for non-invasive detection of bleeding and musculoskeletal abnormalities in patients with hemophilia: an observational study7
A comprehensive model for assessing and classifying patients with thrombotic microangiopathy: the TMA-INSIGHT score7
Lupus anticoagulant associated with low grade B-cell lymphoma and IgM paraproteinaemia with lupus cofactor phenomenon on DRVVT and SCT assays - a possible novel association7
Efficacy and safety of rivaroxaban for the treatment of PICC-related upper extremity deep vein thrombosis in cancer patients: a retrospective study7
Cardiovascular risk factors are associated with augmented thrombogenicity in healthy individuals: analysis using the Total Thrombus-formation Analysis System7
Laboratory evaluation of a new integrative assay to phenotype plasma fibrinolytic system7
A catastrophic seronegative anti-phospholipid syndrome: case and literature review7
Comparison between canine and porcine models of chronic deep venous thrombosis7
Anticoagulation may contribute to antimicrobial treatment of Lemierre syndrome: a case report6
Serial markers of coagulation and inflammation and the occurrence of clinical pulmonary thromboembolism in mechanically ventilated patients with SARS-CoV-2 infection; the prospective Maastricht intens6
The evolution of clot strength in critically ill COVID-19 patients: a prospective observational thromboelastography study6
Venous thromboembolic disease in admitted blunt trauma patients: what matters?6
Effect of frozen storage conditions on antithrombin protein C and protein S activity assay stability6
Thrombotic antiphospholipid syndrome in a child with human immunodeficiency virus: a rare case report6
Insight into antiphospholipid syndrome: the role and clinical utility of neutrophils extracellular traps formation6
Monitoring coagulation-fibrinolysis activation prompted timely diagnosis of hemophagocytic lymphohistiocytosis-related disseminated intravascular coagulation6
A prediction model for left ventricular thrombus persistence/recurrence: based on a prospective study and a retrospective study6
Apixaban anti-Xa level monitoring in treatment of acute upper extremity deep vein thrombosis for patient on chronic hemodialysis: a case report6
Changes of antithrombotic prescription in atrial fibrillation patients with acute coronary syndrome or percutaneous coronary intervention and the subsequent impact on long-term outcomes: a longitudina6
LINC00659 exacerbates endothelial progenitor cell dysfunction in deep vein thrombosis of the lower extremities by activating DNMT3A-mediated FGF1 promoter methylation6
Renal damage and old age: risk factors for thrombosis in patients with ANCA-associated vasculitis5
Risk of heparinoid use in cosmetics and moisturizers in individuals vaccinated against severe acute respiratory syndrome coronavirus 25
Low incidence of venous thrombosis but high incidence of arterial thrombotic complications among critically ill COVID-19 patients in Singapore5
Simplified predictive scores for thrombosis and bleeding complications in newly diagnosed acute leukemia patients5
Incidence and risk factors of venous thrombotic events in patients with interstitial lung disease during hospitalization5
Prevalence and risk factor of post-operative lower extremities deep vein thrombosis in patients undergoing gynecologic surgery: a single-institute cross-sectional study5
The precision of ROTEM EXTEM is decreased in hypocoagulable blood: a prospective observational study5
A thrombophilia family with protein S deficiency due to protein translation disorders caused by a Leu607Ser heterozygous mutation in PROS15
Acute lower limb ischemia caused by vaccine-induced immune thrombotic thrombocytopenia: focus on perioperative considerations for 2 cases5
Adrenal hemorrhage following direct oral anticoagulant (DOAC) therapy: two case reports and literature review5
Artificial intelligence in thrombosis: transformative potential and emerging challenges5
A primary pulmonary artery sarcoma masquerading pulmonary embolism: a case report and literature review5
Development and external validation of prognostic scoring models for portal vein thrombosis: a multicenter retrospective study5
Prediction of residual ischemic risk in ticagrelor-treated patients with acute coronary syndrome5
Prevalence, predictors and management of left atrial appendage thrombogenic milieu in atrial fibrillation with low thromboembolic risk5
Unprovoked venous thromboembolism recurrence and arterial embolism revealing lung cancer: a case report5
The association of serum total bile acids and deep venous thrombosis5
Point of care diagnostic of hypercoagulability and platelet function in COVID-19 induced acute respiratory distress syndrome: a retrospective observational study5
Evaluation of the analytical performance of the PC100 platelet counter4
Impact of oral anticoagulation therapy on postoperative atrial fibrillation outcomes: a systematic review and meta-analysis4
Optimal authoritative risk assessment score of Cancer-associated venous thromboembolism for hospitalized medical patients with lung Cancer4
Low-density lipoprotein cholesterol-to-lymphocyte count ratio (LLR) is a promising novel predictor of postoperative new-onset deep vein thrombosis following open wedge high tibial osteotomy: a propens4
Platelet factor 4 polyanion immune complexes: heparin induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia4
Review article inferior vena cava thrombosis: a case series of patients observed in Taiwan and literature review4
Direct oral anticoagulants versus low molecular weight heparins for the treatment of cancer-associated thrombosis: a cost-effectiveness analysis4
How to exclude pulmonary embolism in patients hospitalized with COVID-19: a comparison of predictive scores4
Pathological findings in rotation thromboelastometry associated with thromboembolic events in COVID-19 patients4
Incidence of anti-platelet factor4/polyanionic antibodies, thrombocytopenia, and thrombosis after COVID-19 vaccination with ChAdOx1 nCoV-19 in Thais4
Vaccine-induced thrombotic thrombocytopenia (VITT): first report from India4
Reduced mortality associated with pulmonary embolism response team consultation for intermediate and high-risk pulmonary embolism: a retrospective cohort study4
The role of Sphingomyelin synthase 2 (SMS2) in platelet activation and its clinical significance4
The usefulness of tranexamic acid for bleeding symptoms of chronic consumptive coagulopathy complicated by aortic disease: a single-institute, retrospective study of 14 patients4
Molecular patterns of alpha-thalassemia in the kingdom of Saudi Arabia: identification of prevalent genotypes and regions with high incidence4
Cardiac thrombus in acute ischemic stroke: impact on endovascular thrombectomy utilization4
The clinical application of venous ultrasound in diagnosis and follow-up of lower extremity deep vein thrombosis (DVT): a case-based discussion4
The effect of recombinant versus plasma-derived von Willebrand factor on prolonged PFA closure times in ECMO patients with acquired von Willebrand syndrome – an observational study4
Long noncoding RNA TUG1 induces angiogenesis of endothelial progenitor cells and dissolution of deep vein thrombosis4
Exercise transiently increases the density of incipient blood clots in antiplatelet-treated lacunar stroke patients4
Efficacy and safety of direct oral anticoagulants in patients with atrial fibrillation combined with chronic kidney disease: a systematic review and meta-analysis4
Coagulation biomarkers and coronavirus disease 2019 phenotyping: a prospective cohort study4
Lipoprotein apheresis: an established therapeutic modality for homozygous familial hypercholesterolemia patients refractory to PCSK9 inhibitors: a case report and literature review4
The Buerger’s rabbit model: a closer step to unravelling thromboangiitis obliterans?4
Heterozygosity for the Budapest 3 mutation in SERPINC1 in a family with thrombophilia and structural anomalies of the inferior vena cava4
The relationship between self-efficacy and treatment satisfaction among patients with anticoagulant therapy: a cross-sectional study from a developing country4
Frontline use of rituximab may prevent ADAMTS13 inhibitor boosting during caplacizumab treatment in patients with iTTP: post hoc analysis of a phase 2/3 study in Japan4
ADAMTS13 activity decreases in the early phase of trauma associated with coagulopathy and systemic inflammation: a prospective observational study3
Intercellular adhesion molecule 4 and ischemic stroke: a two-sample Mendelian randomization study3
Preoperative coagulation biomarkers associate with survival and pulmonary embolism after surgical treatment of non-spinal skeletal metastases3
GDF15 affects venous thrombosis by promoting EndMT through smad2/p-smad2 pathway3
The effect of neutrophil extracellular traps in venous thrombosis3
Direct oral anticoagulants versus low-molecular-weight heparins for the treatment of acute venous thromboembolism in patients with gastrointestinal cancer: a systematic review and meta-analysis3
Coagulation dysfunction events associated with tigecycline: a real-world study from FDA adverse event reporting system (FAERS) database3
Application of a scoring system in Japanese patients diagnosed with atypical hemolytic uremic syndrome to assess the relationship between the score and clinical responses to eculizumab3
Causal relationship between varicose veins and mean corpuscular hemoglobin concentration based on Mendelian randomization study3
Establishment and validation of a nomogram predicting the risk of deep vein thrombosis before total knee arthroplasty3
Antibiotic use in acute mesenteric ischemia: a review of the evidence and call to action3
Pregnancy and thrombosis risk for women without a history of thrombotic events: a retrospective study of the real risks3
Postoperative intermittent pneumatic compression for preventing venous thromboembolism in Chinese lung cancer patients: a randomized clinical trial3
The genetic causal relationship between type 2 diabetes, glycemic traits and venous thromboembolism, deep vein thrombosis, pulmonary embolism: a two-sample Mendelian randomization study3
The evolution of clot strength in critically-ill COVID-19 patients: a prospective observational thromboelastography study3
Pregnancy complications in G20210A mutation carriers associated with high prothrombin activity3
Causal effect of gut microbiota on venous thromboembolism: a two-sample mendelian randomization study3
Cerebral venous sinus thrombosis associated with SRA-negative heparin-induced thrombocytopenia: case report3
Current and future strategies to monitor and manage coagulation in ECMO patients3
COVID19 infection in a patient undergoing treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH) with Ravulizumab3
Lemierre’s syndrome complicating deep neck abscess: a case report3
Effect of therapeutic versus prophylactic anticoagulation therapy on clinical outcomes in COVID-19 patients: a systematic review with an updated meta-analysis3
Implementation of early prophylaxis for deep-vein thrombosis in intracerebral hemorrhage patients: an observational study from the Chinese Stroke Center Alliance3
High-resolution magnetic resonance imaging-based radiomic features aid in selecting endovascular candidates among patients with cerebral venous sinus thrombosis3
Use of thromboelastography before the administration of hemostatic agents to safely taper recombinant activated factor VII in acquired hemophilia A: a report of three cases3
An evaluation of venous thromboembolism by whole-body enhanced CT scan for critical COVID-19 pneumonia with markedly rises of coagulopathy related factors: a case series study3
Correction to: agitation-dependent biomechanical forces modulate GPVI receptor expression and platelet adhesion capacity during storage3
Predictors of pulmonary embolism in hospitalized patients with COVID-193
Insulin resistance, metabolic syndrome and micro-RNA-122 serum level in patients with cerebral venous sinus thrombosis: a case-control study3
Bleeding risks with novel oral anticoagulants especially rivaroxaban versus aspirin: a meta-analysis3
Pulmonary embolism in a patient with eltrombopag-treated aplastic anaemia and paroxysmal nocturnal haemoglobinuria clone during COVID-19 pneumonia3
Factors associated with venous thromboembolic disease due to failed thromboprophylaxis3
Safety and efficacy of direct oral anticoagulation in patients with and without radiofrequency ablation of non-valvular atrial fibrillation: a multicenter retrospective cohort study3
Recurrence in isolated distal DVT after anticoagulation: a systematic review and meta-analysis of axial and muscular venous thrombosis3
A retrospective multicenter cohort study of the association between anti-Factor Xa values and death, thromboembolism, and bleeding in patients with critical COVID-193
Correction to: The impact on renal function after longterm use of anticoagulants in atrial fibrillation patients3
Coagulopathy and its associated factors among patients with a bleeding diathesis at the University of Gondar Specialized Referral Hospital, Northwest Ethiopia3
Risk factors and potential predictors of pulmonary embolism in cancer patients undergoing thoracic and abdominopelvic surgery: a case control study2
Coagulation abnormalities in childhood acute lymphoblastic leukemia: assessing the impact of L-asparaginase therapy in Ghana2
miR-1915-3p regulates megakaryocytic and erythroid differentiation by targeting SOCS42
Cerebral venous thrombosis at high altitude: more severe symptoms and specific predisposing factors than plain areas2
Net reclassification index in comparison of prognostic value of disseminated intravascular coagulation diagnostic criteria by Japanese Society on Thrombosis and Hemostasis and International Society on2
C-type lectin-like receptor 2: roles and drug target2
External validation and update of the International Medical Prevention Registry on Venous Thromboembolism bleeding risk score for predicting bleeding in acutely ill hospitalized medical patients: a re2
The methods for removal of direct oral anticoagulants and heparins to improve the monitoring of hemostasis: a narrative literature review2
Successful treatment of lupus anticoagulant hypoprothrombinemia syndrome with rituximab2
Relationships between coagulation factors and thrombin generation in a general population with arterial and venous disease background2
Treatment of pacemaker-induced superior vena cava syndrome by direct oral anticoagulant2
Impact of baseline renal function on the efficacy and safety of different Anticoagulants in Atrial Fibrillation Patients – A cohort study2
Safety and efficacy of endovascular thrombectomy in acute ischemic stroke treated with anticoagulants: a systematic review and meta-analysis2
Factors associated with bleeding events during catheter ablation with uninterrupted periprocedural edoxaban for atrial fibrillation: a subanalysis of the KYU-RABLE study2
Sex-specific associations between systolic, diastolic and pulse pressure and hemostatic parameters in the population-based KORA-Fit study: a cross-sectional study2
Inadequate response to antiplatelet therapy in patients with peripheral artery disease: a prospective cohort study2
Safety, efficacy and prognosis of anticoagulant therapy for portal vein thrombosis in cirrhosis: a retrospective cohort study2
Haemostasis patterns in patients with acute-on-chronic liver failure and acute decompensation of cirrhosis including thromboelastometric tests with and without the addition of Protac: a pilot study2
Efficacy and safety of oral anticoagulants in elderly patients with stable coronary artery disease and atrial fibrillation2
LMWHs dosage and outcomes in acute pulmonary embolism with renal insufficiency, an analysis from a large real-world study2
Superior vena cava syndrome after pacemaker implantation treated with direct oral anticoagulation2
Frequency of deep vein thrombosis at admission for acute stroke and associated factors: a cross-sectional study2
Atrial fibrillation and anticoagulation are associated with hospitalisations in patients with end-stage kidney disease on haemodialysis: a prospective population-based cohort study2
Differences between surviving and non-surviving venous thromboembolism COVID-19 patients: a systematic review2
A case-report of the unprovoked thrombotic event in a patient with thymoma and severe FVII deficiency2
Causal association between circulating blood cell traits and pulmonary embolism: a mendelian randomization study2
Early identification of lung cancer patients with venous thromboembolism: development and validation of a risk prediction model2
Potential value of the calibrated automated thrombogram in patients after a cerebral venous sinus thrombosis; an exploratory study2
Experience of danaparoid to treat vaccine-induced immune thrombocytopenia and thrombosis, VITT2
Restenosis after excimer laser coronary atherectomy and drug-coated balloon dilation in Takayasu’s arteritis: a case report and review of the literature2
Syndecan-1 as a prognostic biomarker in COVID-19 patients: a retrospective study of a Japanese cohort2
The magnitude and associated factors of coagulation abnormalities among liver disease patients at the University of Gondar Comprehensive Specialized Hospital Northwest, Ethiopia, 20222
Vitamin-K-antagonist phenprocoumon versus low-dose direct oral anticoagulants (DOACs) in patients with atrial fibrillation: a real-world analysis of German claims data2
“Y appearance” infarction: caused by essential thrombocythemia2
Effect of direct oral anticoagulant therapy on pulmonary artery clot dissolution in intermediate high-risk pulmonary thromboembolism2
Values and preferences towards the use of prophylactic low-molecular-weight heparin during pregnancy: a convergent mixed-methods secondary analysis of data from the decision analysis in shared decisio2
Adjusted D-dimer cutoff levels to rule out pulmonary embolism in patients hospitalized for COPD exacerbation: results from the SLICE trial2
Diagnostic and prognostic potential of long non-coding RNA NORAD in patients with acute deep vein thrombosis and its role in endothelial cell function2
Sources of bias and limitations of thrombinography: inner filter effect and substrate depletion at the edge of failure algorithm2
Lipoprotein(a) predicts recurrent cardiovascular events in patients with prior cardiovascular events post-PCI: five-year findings from a large single center cohort study2
Comparison of anticoagulated versus non-anticoagulated patients with intra-aortic balloon pumps2
Sex-related differences in the effect of rotational thrombectomy for thrombus-containing lower limbs ischemic lesions2
Anticoagulation strategy and safety in critically ill COVID-19 patients: a French retrospective multicentre study2
Low risk of haematomas with intramuscular vaccines in anticoagulated patients: a systematic review with meta-analysis2
Nonnegligible causes of symptoms of acute lower extremities——3 cases of May-Thurner syndrome with deep vein thrombosis2
Evaluation of prothrombotic risk of two PROC hotspot mutations (Arg189Trp and Lys193del) in Chinese population: a retrospective study1
Structure, signal transduction, activation, and inhibition of integrin αIIbβ31
Mortality data from omission of early thromboprophylaxis in critically ill patients highlights the importance of an individualised diagnosis-related approach1
Causal association between circulating α-Klotho levels and venous thromboembolism: a two-sample Mendelian randomization study1
Identification of key risk factors for venous thromboembolism in urological inpatients based on the Caprini scale and interpretable machine learning methods1
A retrospective cohort study on a novel marker to predict the severity and prognosis of acute cerebral venous thrombosis: D-dimer to fibrinogen ratio1
Risk factors for central venous catheter-associated deep venous thrombosis in pediatric critical care settings identified by fusion model1
Development and validation of a new risk assessment model for immunomodulatory drug-associated venous thrombosis among Chinese patients with multiple myeloma1
Association between inflammatory biomarkers and venous thromboembolism: a systematic review and meta-analysis1
Vascular endothelial growth factor and the risk of venous thromboembolism: a genetic correlation and two-sample Mendelian randomization study1
Advanced pharmacodynamics of cangrelor in healthy volunteers: a dose-finding, open-label, pilot trial1
Association between obstructive sleep apnea and venous thromboembolism recurrence: results from a French cohort1
Enoxaparin-induced reactive thrombocytosis: a case report1
Prognostic value of plasma high mobility group box 1 protein and histone H3 levels in patients with disseminated intravascular coagulation: a multicenter prospective cohort study1
Monitoring the efficiency of reversal on anti-Xa direct oral anticoagulants using point-of-care viscoelastic testing1
Dimethyl fumarate inhibits antibody-induced platelet destruction in immune thrombocytopenia mouse1
Anticoagulation control for nonvalvular atrial fibrillation in a tertiary academic centre in Johannesburg1
Preventive strategies for hypercoagulation in Cushing’s syndrome: when and how1
Reply to correspondence: Cancer incidence and mortality after a first-ever venous thrombosis in northern Sweden1
A 11-year-old boy with Blastocystis hominis infection, presents as immune thrombocytopenia1
Prophylaxis with enoxaparin and antithrombin III in drug-induced coagulation alterations in childhood leukemia: a retrospective experience of 20 years1
Venous thromboembolism in patients with acute myeloid leukemia: development of a predictive model1
SERPINC1 c.1247dupC: a novel SERPINC1 gene mutation associated with familial thrombosis results in a secretion defect and quantitative antithrombin deficiency1
Autopsy and statistical evidence of disturbed hemostasis progress in COVID-19: medical records from 407 patients1
Editorial expression of concern: Lipoxin A4 analogue, BML-111, reduces platelet activation and protects from thrombosis1
Anti-inflammatory and antioxidant efficacy of lavender oil in experimentally induced thrombosis1
Complement C5a induces the generation of neutrophil extracellular traps by inhibiting mitochondrial STAT3 to promote the development of arterial thrombosis1
Correlation between a 2-week change in platelet count and clinical outcomes after the initiation of ravulizumab treatment in adult patients with atypical hemolytic uremic syndrome: post-hoc analysis o1
Thrombosis in COVID-19 infection: Role of platelet activation-mediated immunity1
Intermediate-to-therapeutic versus prophylactic anticoagulation for coagulopathy in hospitalized COVID-19 patients: a systemic review and meta-analysis1
Clinical significance of neutrophil extracellular traps biomarkers in thrombosis1
Right heart thrombus in transit and peripherally inserted central catheters1
Deep venous thrombosis in an individual with statin-exposed anti-SRP myopathy: case report and review of literature1
Acute caval thrombosis leading to obstructive shock in the early post insertion period of an inferior vena cava filter: a case report and literature review1
Evaluation of Apixaban safety and effectiveness in morbidly obese patients with atrial fibrillation: a retrospective cohort study1
Modified thromboelastometric tests provide improved sensitivity and specificity to direct oral anticoagulants compared to standard thromboelastometric tests in-vitro1
Correction: The effect of Mycobacterium tuberculosis treatment on thrombelastography-assessed haemostasis: a prospective cohort study1
0.27257919311523